doxorubicin hydrochloride has been researched along with resveratrol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, J; Bryce, RA; Caraher, MC; Doncaster, JR; Humphries, MP; Nolan, KA; Stratford, IJ; Tirelli, N; Whitehead, RC | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for doxorubicin hydrochloride and resveratrol
Article | Year |
---|---|
Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2.
Topics: Acridines; Animals; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; DNA; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Male; Models, Molecular; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Quinone Reductases; Salmon; Spermatozoa; Structure-Activity Relationship; Transition Temperature; Triazoles | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |